REG - FTSE Russell Dechra Pharmaceutcls Persimmon Plc Baillie Gifford US - Dechra Pharmaceuticals

PersimmonAnnouncement

11/01/2024 18:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240111:nRSK4516Za&default-theme=true

RNS Number : 4516Z  FTSE Russell  11 January 2024

 

 Further to the FTSE notice released on 09 January 2024
 (https://research.ftserussell.com/products/index-notices/home/getnotice/?id=2611255)
 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion,  please
 note the replacement in the fixed indices.

 All other details remain unchanged. Please see updated notice below:

Dechra Pharmaceuticals (UK): Constituent Deletion - Update

Changes in FTSE UK Index Series

11 January 2024

 Subject to court sanctioning the scheme of arrangement in relation to the cash
 offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited
 (non-constituent), please see details of affected indexes and effective dates
 below:

 Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index.

 Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted
 from the FTSE 250 Index.

 Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250
 Index and deleted from the FTSE SmallCap Index.

 All changes effective from 16 January 2024

 Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

 

 For further information please contact FTSE Russell Client Services at
 info@ftserussell.com or call:

Australia  +61 (0) 2 7228 5659
 Hong Kong  +852 2164 3333
 Japan      +81 3 6441 1430
 London     +44 (0) 20 7866 1810
 New York   +1877 503 6437

 

 Alternatively please visit our website at lseg.com/ftse-russell

 Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
 © 2024 FTSE Russell

 

 

Alternatively please visit our website at lseg.com/ftse-russell

 

Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
© 2024 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FTSFLFLDLIILLIS